Kusurinomadoguchi (5592) Q4 2025 earnings summary

Executive summary

• Revenue increased 28.4% year-over-year to ¥11.19 billion, with operating profit up 43% and net income attributable to shareholders up 134%, driven by strong media and core system businesses and subsidiary-developed electronic prescription management systems.

• The company benefited from a one-time special demand, contributing approximately ¥500 million in sales and ¥300 million in operating profit.

• Net income surged to ¥2.034 billion, aided by the absorption of a wholly owned subsidiary and the carryforward of tax losses.

Financial highlights

• Consolidated revenue: ¥11.19 billion (+28% YoY); operating profit: ¥1.953 billion (+43% YoY); EBITDA: ¥3.178 billion (+37% YoY); net income: ¥2.034 billion (+134% YoY).

• Stock sales increased 23% YoY to ¥7.24 billion; shot sales rose 40% YoY to ¥3.95 billion.

• Final dividend per share set at ¥27, up 19.3% from previous guidance.

• Cash and equivalents at year-end were ¥2.104 billion, down from ¥14.59 billion due to changes in business scheme and working capital.

• Comprehensive income was ¥2.072 billion, up from ¥874 million the previous year.

Outlook and guidance

• For FY2026, targets revenue of ¥12.3 billion (+15% YoY, excluding one-time subsidy effects) and operating profit of ¥2.2 billion (+33% YoY, adjusted).

• Dividend forecast for FY2026 is ¥30 per share, with a 15% payout ratio.